Summary
VDS PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €503k and a net result of €75k. Equity is growing by ~17.7% per year across the filed fiscal years. Its solvency ranks better than 59% of 5527 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 14-04-2026, 16 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
16 d early
2024
19 d early
2023
5 d early
2022
37 d early
2021
1 d early
2020
on the day
2019
20 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€503k▲ 11.9%
2024 · €449k
2018: €112k
2019: €157k
2020: €210k
2021: €283k
2022: €373k
2023: €447k
2024: €449k
2018 → 2025
Net result
€75k▲ 333%
2024 · €17k
2018: €81k
2019: €45k
2020: €54k
2021: €73k
2022: €98k
2023: €91k
2024: €17k
2018 → 2025
Total assets
€822k▼ 1.4%
2024 · €834k
2018: €612k
2019: €621k
2020: €619k
2021: €667k
2022: €853k
2023: €891k
2024: €834k
2018 → 2025
Solvency
61.2%▲ 7.3pp
2024 · 53.9%
2018: 18.3%
2019: 25.4%
2020: 34.0%
2021: 42.5%
2022: 43.8%
2023: 50.2%
2024: 53.9%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€283k-€373k▲ 31.8%€447k▲ 19.8%€449k▲ 0.5%€503k▲ 11.9%
Operating result€100k-€128k▲ 27.7%€127k▼ 1.2%€34k▼ 73.3%€105k▲ 210%
Net result€73k-€98k▲ 34.2%€91k▼ 6.4%€17k▼ 81.1%€75k▲ 333%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 210% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €822k
Fixed assets
€716k =
Current assets
€106k ▼ 10.2%
Equity and liabilities €822k
Equity
€503k ▲ 11.9%
Debt
€319k ▼ 17.0%
Debt's share of the balance-sheet total falls from 46.1% to 38.8%. Equity is higher and debt is lower.
Key figures and ratios
ROE
14.8%▲
2024 · 3.8%
ROA
9.1%▲
2024 · 2.1%
Debt ≤ 1 year
€142k▼
2024 · €166k
Debt > 1 year
€177k▼
2024 · €217k
Income taxes
€20k▲
2024 · €7k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet
Code20242025
Assets
Total assets20/58€834k€822k▼
Fixed assets21/28€716k€716k=
Financial fixed assets28€716k€716k=
Current assets29/58€118k€106k▼
Amounts receivable within one year40/41€110k€82k▼
Trade receivables40€93k€80k▼
Other amounts receivable41€17k€2k▼
Cash at bank and in hand54/58€8k€24k▲
Equity and liabilities
Total equity and liabilities10/49€834k€822k▼
Equity10/15€449k€503k▲
Contributions10/11€19k€19k=
Reserves13€431k€484k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€431k€484k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€384k€319k▼
Amounts payable after more than one year17€217k€177k▼
Financial debts170/4€217k€177k▼
Amounts payable within one year42/48€166k€142k▼
Current portion of amounts payable after more than one year42€51k€52k▲
Trade debts44€6k€3k▼
Suppliers440/4€6k€3k▼
Taxes, remuneration and social security45€10k€10k▲
Taxes450/3€10k€10k▲
Remuneration and social security454/9€0-
Other amounts payable47/48€98k€77k▼
Accrued charges and deferred income492/3€772€175▼
Income statement
Code20242025
Non-recurring operating income76A€1k€0▼
Other operating charges640/8€891€1k▲
Non-recurring operating charges66A€2k€532▼
Gross operating margin9900€36k€107k▲
Operating profit (loss)9901€34k€105k▲
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€10k€10k▲
Recurring financial charges65€10k€10k▲
Profit (loss) for the period before taxes9903€24k€95k▲
Income taxes67/77€7k€20k▲
Profit (loss) for the period9904€17k€75k▲
Profit (loss) for the period to be appropriated9905€17k€75k▲
Appropriation of the result
Profit (loss) to be appropriated9906€17k€75k▲
Transfer to equity691/2€2k€53k▲
To other reserves6921€2k€53k▲
Profit to be distributed694/7€15k€21k▲
Return on contributions (dividend)694€15k€21k▲
Social balance
Average headcount (FTE)90870.00.0=
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-04
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-09
Financial
Equity above €500kEq €503k ▲11.9%
8 profitable years in a row build equity to €503k.
11-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-09
Financial
Weakest financial yearnet €17k ▼81.1%
Net result drops to €17k, the lowest in the series; recovery starts the following year.
25-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
24-03
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Highest result since 2018net €98k ▲34.2%
Net result €98k, the highest in the series.
29-04
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial
Equity above €200kEq €210k ▲33.6%
3 profitable years in a row build equity to €210k.
10-04
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-09
Financial
Equity above €150kEq €157k ▲40.2%
2 profitable years in a row build equity to €157k.
Show earlier events
02-04
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
03-04
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
31-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Pieters-Leeuw · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zuundallaan 221600 Sint-Pieters-LeeuwGround area
785 m²
Building footprint
181 m²
Volume, LiDAR
853 m³
Parcel 23077C0033/00D000, Flanders · tallest building 7.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
VDS Pharma
since 20152.239.917.763
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23077C0033/00D000 | Flanders | 785 m² | 1 · 181 m² | 7.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
FABRY MARC INVEST
BE 0635.918.340
Lontzen · Eq €502,882
CVW INVEST
BE 0686.771.975
Pepinster · Eq €502,962
CINQUE
BE 0477.626.614
Tournai · Eq €502,681
VEMACO HOLDING
BE 0822.118.649
Kapelle-op-den-Bos · Eq €503,096
LYRIK
BE 0803.720.620
Sint-Jans-Molenbeek · Eq €502,368
Of 24,725 companies in sector 64210 we hold annual accounts for 19,762. 13,606 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-02-2015
Fiscal year end30-09
Activities, NACEBEL 2025
64210Activities of holding companies
70200Business and other management consultancy
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.